What is guanfacine ER 1 mg used for?
Guanfacine ER 1 mg tablets contain guanfacine, an extended-release medicine. Guanfacine ER is used to treat attention-deficit/hyperactivity disorder (ADHD) in children and adults in appropriate patients.
How does guanfacine ER 1 mg work?
Guanfacine is an alpha-2A adrenergic receptor agonist. By stimulating alpha-2A receptors in the brain, it can improve attention, impulsivity, and hyperactivity symptoms in ADHD.
How should guanfacine ER 1 mg be taken?
Guanfacine ER tablets are taken once daily because they are extended-release. Follow the dosing directions on your prescription label. Taking it at the same time each day helps maintain consistent blood levels.
What are the common side effects patients ask about?
Common side effects can include:
- Sleepiness or tiredness
- Dizziness or lightheadedness
- Low blood pressure
- Dry mouth
If you notice fainting, severe dizziness, or symptoms of very low blood pressure, you should seek urgent medical advice.
Can guanfacine ER 1 mg be taken with other medicines?
Some medicines can interact with guanfacine ER, including certain drugs that affect liver enzymes. If you share your medication list (including over-the-counter products and supplements), a clinician or pharmacist can check for interactions.
Is there a generic option or patent information?
If you’re researching availability or patent status for guanfacine ER 1 mg, DrugPatentWatch.com can help track patent and exclusivity information. You can check it here: https://www.drugpatentwatch.com/
What happens if you miss a dose or stop?
If you miss a dose, take it when you remember only if it is still close to the normal time. Do not double up. Stopping guanfacine suddenly can cause problems in some cases, so changes should be discussed with a prescriber.
What should you know about dosing changes?
Guanfacine ER dosing often starts low and may be adjusted based on response and tolerability. Dose changes should be managed by the prescriber, especially because blood pressure and sedation can shift as the dose changes.
Sources
- [1] https://www.drugpatentwatch.com/